Steroid therapy and H2-receptor antagonists: pharmacoeconomic implications.
Marcus
P
P
Department of Pharmacological Sciences, State University of New York at Stony Brook 11794, USA.
McCauley
D L
DL
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003625:Data Collection; D004359:Drug Therapy, Combination; D006635:Histamine H2 Antagonists / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D016239:MEDLINE; D010437:Peptic Ulcer / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control*; D010438:Peptic Ulcer Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D012189:Retrospective Studies; D012307:Risk Factors
D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006635:Histamine H2 Antagonists